HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randy Dockens Selected Research

Cognitive Dysfunction

11/2015Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial.
1/2013A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Randy Dockens Research Topics

Disease

4Alzheimer Disease (Alzheimer's Disease)
11/2015 - 10/2012
2Cognitive Dysfunction
11/2015 - 01/2013
2Skin Neoplasms (Skin Cancer)
11/2015 - 11/2012
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2023
1Cellulitis
01/2022
1Pharyngitis (Sore Throat)
01/2022
1Lymphadenopathy
01/2022
1Atrophy
11/2015
1Dementia (Dementias)
11/2015
1Disease Progression
11/2015
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
10/2012
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
06/2009

Drug/Important Bio-Agent (IBA)

4BMS 708163IBA
11/2015 - 10/2012
2deucravacitinibIBA
12/2023 - 01/2022
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2015 - 11/2012
1Tyrosine (L-Tyrosine)FDA Link
12/2023
1CytokinesIBA
12/2023
1Biomarkers (Surrogate Marker)IBA
11/2015
1Glucose (Dextrose)FDA LinkGeneric
11/2012
1Adrenocorticotropic Hormone (ACTH)FDA Link
06/2009